A PYMNTS Company

EU: $13.4B orthopedic merger to meet its fate next month

By  |  September 1, 2014

The European Commission has announced that it will decide by October 3 whether to accept or deny plans of a $13.4 billion orthopedic merger.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    According to reports, US-based orthopedic product maker Zimmer will receive a decision regarding its planned acquisition of rival Biomet next month. Zimmer first applied for EU approval of its plans last June, but the Commission had requested more information regarding the transaction, causing a delay to the ruling.

    Reports say if cleared, the merger would make Zimmer the second-largest seller of orthopedic products behind Johnson & Johnson.

    Full content: Reuters

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.